UNIVERSITYOF PORTSMOUTH
M33319 - Applied Pharmacology of the Nervous and Endocrine System
Modulators of Neuronal Excitability
Ngan Pan Bennett Au, PhD
Lecturer in Pharmacology (Neuroscience)
School of Pharmacy and Biomedical Science,
University of Portsmouth
Learning Objectives
- Identify the various classes of drugs that target axonal voltage-gated ion
channels, and their mechanisms of action in altering neuronal activity.
- Identify the various classes of drugs that target monoaminergic
neurotransmitters/receptors/transporters, and their mechanisms of action
in altering neuronal activity.
- Identify the appropriate clinical indications for these different drugs.
Drugs Covered in This Lecture
a
Somatodendritic
Axonal
Intracellular recording
Action potentials
Excitatory inputs
Kv4.2
Kv3 throughout dendrite
Proximal
dendrites
Kv2.1
EPSPs
0
-
8
88
Distal
dendrites
PP
888
0
-
8
P
Nodes of Ranvier
Nav, KCNQ. Kv3.1b
HCN
Cav
Inhibitory
inputs
IPSPs
AIS
Nav, KCNQ
Dendritic action potentials
4
Neurotransmitter
release
Dopamine neuron
Noradrenaline neuron
5-Hydroxytryptamine neuron
Tyrosine
Amph.
MPP+
Cocaine
GBR 12935
WIN 35,428
RTI-121
Amph.
L-DOPA
L-DOPA
Cocaine
Nisoxetine
Reboxetine
5-hydroxytryptophan
DA
DA
5-HT
*
d
DA
DA
5-HT
NA
DAT
1
NET
SERT
DA
Adrenergic .
autoreceptors
5-HT
autoreceptors
DA receptors
Adrenergic receptors
5-HT receptors
Drugs targeting axonal
voltage-gated ion channels
Tyrosine
Tryptophan
Amph.
MDMA
Cocaine
Fluoxetine
Paroxetine
Sertraline
Back propagation
Nav, Kv1, Cav
Presynaptic
nerve
terminals
P
Soma
Kv1
IXPs
8
O
8
autoreceptors
Drugs targeting monoaminergic
neurotransmitters
Types of Voltage-Gated Ion Channels
a
Somatodendritic
Axonal
Intracellular recording
Action potentials
Excitatory inputs
Kv4.2
Kv3 throughout dendrite
Proximal
dendrites
Kv2.1
EPSPs
Soma
Kv1
IXPs
0
o
A
Distal
dendrites
8
88
O
=
Nodes of Ranvier
Nav. KCNQ. Kv3.1b
0
HCN
Cav
Inhibitory
inputs
IPSPs
AIS
Nav, KCNQ
O
o
Dendritic action potentials
Back propagation
Neurotransmitter
release
Membrane potential (mv
3 voltage-gated Na+
channel inactivated
(no ion flow)
voltage-gated K+
4 channel opens,
K+ leaves cell
2 voltage-gated Na+
channel opens;
time
Na+ rushes in
resting potential re-established,
Na+ channel closed (not
inactive)
-50
1 voltage-gated Na+
channel
closed
time of stimulation
- Voltage-gated sodium (Nav) ion channels
- Voltage-gated potassium (Kv) ion channels
- Voltage-gated calcium (Cav) ion channels
- Abundantly expressed in axon initial segment (AIS)
. Determine the threshold for firing an action potential
- Action potential propagates along the axon and reach the axonal terminal
- Activate Cav
- Calcium influx and neurotransmitter release
4
+50
Nav, Kv1, Cav
Presynaptic
nerve
terminals
0
OUNIVERSITYOF
PORTSMOUTH
Voltage-Gated Sodium Channels
- 10 different Nav identified in mammals
- Nav1.1 - Nav1.9 and atypical NavX
- Based on the difference in a-subunit
- All are expressed in nervous system, except Nav1.4
- CNS: Nav1.1 - Nav1.3, Nav1.5, Nav1.6
- PNS: Nav1.7 - Nav1.9
- a-subunit (260 kDa): pore-forming
- 4 homologous transmembrane domain I-IV
- Each domain has six hydrophobic a-helical transmembrane segments (S1-S6)
- S4: voltage sensor (change in membrane potential) - related to activation of
Nav
- TTX (tetrodotoxin)-sensitive: Nav1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.6, Nav1.7
- TTX-resistant: Nav1.5, Nav1.8, Nav1.9
- 3 intracellular loops
A
₿1/3-subunit
c-subunit
฿ 2/4-subunit
=
=
IV
NH
NH
Voltage
sensor
Outside
C
C
wow !!
1 2345 6
12 345 6 12345 6
12345 6
Inside
COOH
COOH
PY
motif
ER-retention
signals (Na,1.5)
Endocytic
motif
AnkyrinG
-binding site
Di-leucine
motif
B
Na
-
Pore loops
1
5
4
2
13
IV
=
IFM
+ Inactivation gate
5
COOH
NH
Voltage-Gated Sodium Channels: Beta-Subunit
- ß-subunit (33-36 kDa): auxiliary subunits
- Contains three major parts:
- Independent transmembrane domain
- Small intracellular C-terminal
- Large intracellular N-terminal
- 4 subtypes: 31-34
- Regulate a-subunit (gated kinetics, voltage-dependence,
localisation)
Navß isoforms Distribution in neurons
ß1
mainly in large or medium (>30 pm) DRG neurons, less in smaller neurons (<25 um)
฿ 2
widely distributed in CNS and PNS neurons, including cerebral and DRG neurons
฿ 3
mainly in small (<25 um) and medium (25-45 um) neurons, less in large (>45 um) neurons
฿ 4
mainly in large neurons, less in medium and small neurons
A
₿1/3-subunit
c-subunit
฿ 2/4-subunit
=
=
IV
NH
NH
Voltage
sensor
Outside
C
C
wow !!
1 2345 6
12 345 6 12345 6
12345 6
Inside
COOH
Inactivation
gate
COOH
PY
motif
ER-retention
signals (Na_1.5)
Endocytic
motif
AnkyrinG
-binding site
Di-leucine
motif
B
Na
-
Pore loops
1
5
4
2
13
IV
=
IFM
+ Inactivation gate
6
6
COOH
NH
Modulators of Voltage-Gated Sodium Channels: Phenytoin
- Act as a non-specific sodium channel blocker
. Stabilise the Nay channels that are inactivated
- Prolong the refractory period of a neuron
- Blockade of sodium-dependent action potentials depends on:
- Voltage: Nav inactivated at positive (+30mV) membrane potential
- Use: ultimately reduce sustained high-frequency firing of action
potential
- Time: time required to dissociate from binding of the drug to Nav
channels
- Reduce synaptic release of glutamate
Medical indication
- Epilepsy/seizures following neurosurgery or severe head injury
Open
Inactivated
Na+
Na+
A
A
1
carbamazepine
phenytoin
topiramate
Na+
lamotrigine
valproate
zonisamide
Control
Phenytoin
1
On
Off On
Off
peak AP
+35
-----
D
depolarization (Na' influx)
repolarization (K+ efflux)
relative
refractory
period
55
threshold
------
resting
- 70
hyperpolar-
ization
absolute
refractory
period
Na+
transmembrane potential (mV)
time (ms)
7UNIVERSITYOF
PORTSMOUTH
Modulators of Voltage-Gated Sodium Channels: Carbamazepine
- Act as a non-specific sodium channel blocker
- Also bind to other voltage-gated ion channels (e.g. Cav channels)
- Stabilise the Nay channels that are inactivated
- Prolong the refractory period of a neuron
- Fewer Nay channels to open and prevent the generation of action
potential
- Reduce neuronal excitability
Medical indication
- Epilepsy
- Trigeminal Neuralgia (sudden and severe facial pain caused by
compression of trigeminal nerve)
- Mania (abnormally elevated arousal and energy level)
Open
Inactivated
Na+
Na+
A
A
1
carbamazepine
phenytoin
topiramate
Na+
Na+
Carbamazepine
+35
----
D
depolarization (Na' influx)
repolarization (K+ efflux)
K
relative
refractory
period
. 55
threshold
-------
resting
. 70
--
hyperpolar-
ization
absolute
refractory
period
On
Off
lamotrigine
valproate
zonisamide
peak AP
transmembrane potential (mV)
time (ms)
8UNIVERSITYOF
PORTSMOUTH
Voltage-Gated Calcium Channels
- Ca2+: second messenger within the cells for regulation of
many signalling pathways
- Cav: activate upon membrane depolarisation and
mediate Ca2+ influx in response to action potentials and
sub-threshold depolarisation signals.
- Five subunits:
- a1: pore-forming subunit; 4 homologous I-IV domain
(each contains 6 transmembrane helices S1-S6);
voltage-sensing
- a28: disulfide-linked glycoprotein dimer; drug target for
gabapentinoids
- B: intracellular subunit; stabilise the conformation of a1
- y: transmembrane glycoprotein subunit
Ca2+
a2
Y
α1
Contraction
Secretion
Synaptic transmission
Protein
phosphorylation
Enzyme
regulation
Nucleus
1
XXX
Gene transcriptionUNIVERSITYOF
PORTSMOUTH
Types of Voltage-Gated Calcium Channels
- Five types of Cav:
- L-type (long-lasting via DHP receptors)
- N-type (neural; found in brain and PNS)
- P-type (Purkinje; cerebellum)
- R-type (residual; cerebellar granule cells and
neurons)
- T-type (transient; many neurons, cells with
pacemaker activity; thalamus)
Ca2+
a2
8
Y
α1
Contraction
Secretion
Synaptic transmission
Protein
phosphorylation
Enzyme
regulation
Nucleus
1
Gene transcriptionTable 1. Subunit composition and function of Ca2+ channel types
Ca2+ current
&1
Subunits
Specific
blocker
Principal physiological functions
Inherited diseases
L
Cav1.1
DHPs
Excitation-contraction coupling in
skeletal muscle, regulation of
transcription
Hypokalemic periodic
paralysis
Cay1.2
DHPs
Excitation-contraction coupling in
cardiac and smooth muscle,
endocrine secretion, neuronal
Ca2+ transients in cell bodies and
dendrites, regulation of enzyme
activity, regulation of transcription
Timothy syndrome: cardiac
arrhythmia with
developmental
abnormalites and autism
spectrum disorders
Cav1.3
DHPs
Endocrine secretion, cardiac
pacemaking, neuronal Ca2+
transients in cell bodies and
dendrites, auditory transduction
Cay1.4
DHPs
Visual transduction
Stationary night blindness
N
Cav2.1
@-CTx-GVIA Neurotransmitter release,
Dendritic Ca2+ transients
P/Q
Cav2.2
@-Agatoxin
Neurotransmitter release,
Dendritic Ca2+ transients
Familial hemiplegic migraine,
cerebellar ataxia
R
Cay2.3
SNX-482
Neurotransmitter release,
Dendritic Ca2+ transients
T
Cay3.1
None
Cay3.2
Pacemaking and repetitive firing
Pacemaking and repetitive firing
Absence seizures
Cay3.3
Abbreviations: DHP, dihydropyridine; @-CTx-GVIA, @-conotoxin GVIA from the cone snail Conus geographus; SNX-482, a
synthetic version of a peptide toxin from the tarantula Hysterocrates gigas.
11
UNIVERSITYOF
PORTSMOUTH
type
Modulators of Voltage-Gated Calcium Channels: Ethosuximide
- Block T-type calcium channels
- T-type calcium channels are:
- Low-threshold calcium spikes: appear when neuronal
membrane potentials are below -69mV
- Amplitude of depolarisation is ~25mV: raise the membrane
potential to -40mV
- Opening of Nav: burst of action potential
- Burst-firing is observed in rodent models of absence epilepsy
Medical indications
- treatment of absence seizures
A
Regular firing
B
Burst firing
10 mV
40 ms
-55 mV
-75 mV
C
Action potential
(high-threshold
Na+ spike)
D
Low-threshold
Ca2+ spike
10 mV
40 ms
10 mV
T channels
opening and closing
-46 mV
4 ms
-63 mV
12UNIVERSITYOF
PORTSMOUTH
Modulators of Voltage-Gated Calcium Channels: Gabapentin
- Ligand of a28 calcium channel subunit (modulate a1 functions and stabilize cellular
localisation of Cav)
- Bind to a28 and impair its regulatory functions and protein-protein interactions
with other proteins
- Block the translocation of Cay towards the cell membrane
- Lower the amount of functional Cav at presynaptic terminals
- Reduce neurotransmitter release & neuronal excitability
Medical indications
- Epilepsy
- Neuropathic pain
- Spasticity (rigid muscles) in multiple sclerosis
Hyperexcited Neuron
Presynaptic
Subunit
Channel
Neurotransmitters
Postsynaptic
Modulation of Hyperexcited Neuron
With Pregabalin
Presynaptic
Pregabalin
C2-8
Subunit
Ca2+
Channel
- --- --
Neurotransmitters
Postsynaptic